Patent · US Expired

Modified HIV Env polypeptides

US7662916B2 · kind B2 · utility

0Cited by

76References

11Claims

0Family size

Assignee

Novartis Vaccines and Diagnostics, Inc. · US

Inventors

Susan Barnett · San Francisco, US
Karin Hartog · Piedmont, US
Eric Martin · Corona, US

Key dates

Filing date	Jul 25, 2003
Grant date	Feb 16, 2010
Priority date	—
Expiry date	Nov 30, 2023

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2770/24222
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Polynucleotide encoding modified HIV Env polypeptides are disclosed. The Env polypeptides are modified so as to expose at least part of the CD4 binding region. Methods of diagnosis, treatment and prevention using the polynucleotides and polypeptides are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.